Shanghai Sanyou Medical Co., Ltd (SHA:688085)
China
· Delayed Price · Currency is CNY 17.28
-0.27 (-1.54%)
Apr 28, 2025, 2:45 PM CST
Shanghai Sanyou Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 452.64 | 456.91 | 647.8 | 592.95 | 390.35 | Upgrade
|
| Other Revenue | - | 3.48 | 1.35 | 0.41 | 0.08 | Upgrade
|
| Revenue | 452.64 | 460.39 | 649.15 | 593.36 | 390.43 | Upgrade
|
| Revenue Growth (YoY) | -1.68% | -29.08% | 9.40% | 51.98% | 10.19% | Upgrade
|
| Cost of Revenue | - | 103.81 | 71.39 | 63.61 | 40.27 | Upgrade
|
| Gross Profit | 452.64 | 356.58 | 577.77 | 529.75 | 350.17 | Upgrade
|
| Selling, General & Admin | - | 193.48 | 333.64 | 323.13 | 205.42 | Upgrade
|
| Research & Development | 84.12 | 65.22 | 60.38 | 56.55 | 33.92 | Upgrade
|
| Other Operating Expenses | 353.78 | 5.07 | 7.68 | 6.49 | 4 | Upgrade
|
| Operating Expenses | 437.89 | 255 | 404.49 | 389.04 | 245.83 | Upgrade
|
| Operating Income | 14.75 | 101.58 | 173.28 | 140.71 | 104.33 | Upgrade
|
| Interest Expense | - | -0.27 | -0.2 | -0.16 | - | Upgrade
|
| Interest & Investment Income | - | 16.25 | 14.53 | 34.3 | 23.66 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.32 | 0.1 | -0.17 | -0.33 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.91 | -0.31 | -0.2 | 0.19 | 1.67 | Upgrade
|
| EBT Excluding Unusual Items | 21.66 | 117.58 | 187.51 | 174.87 | 129.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -6.89 | 36.32 | 27.33 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.05 | -0.06 | -0.19 | - | Upgrade
|
| Other Unusual Items | - | 24.22 | 15.78 | 15.33 | 7.61 | Upgrade
|
| Pretax Income | 21.66 | 134.87 | 239.54 | 217.33 | 136.95 | Upgrade
|
| Income Tax Expense | 10.36 | 21.23 | 35.99 | 22.18 | 18.39 | Upgrade
|
| Earnings From Continuing Operations | 11.3 | 113.64 | 203.56 | 195.15 | 118.56 | Upgrade
|
| Minority Interest in Earnings | - | -18.06 | -12.74 | -8.78 | - | Upgrade
|
| Net Income | 11.3 | 95.58 | 190.82 | 186.37 | 118.56 | Upgrade
|
| Net Income to Common | 11.3 | 95.58 | 190.82 | 186.37 | 118.56 | Upgrade
|
| Net Income Growth | -88.18% | -49.91% | 2.39% | 57.20% | 21.20% | Upgrade
|
| Shares Outstanding (Basic) | 226 | 252 | 248 | 247 | 228 | Upgrade
|
| Shares Outstanding (Diluted) | 226 | 252 | 248 | 247 | 228 | Upgrade
|
| Shares Change (YoY) | -10.15% | 1.50% | 0.33% | 8.48% | 23.11% | Upgrade
|
| EPS (Basic) | 0.05 | 0.38 | 0.77 | 0.75 | 0.52 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.38 | 0.77 | 0.75 | 0.52 | Upgrade
|
| EPS Growth | -86.84% | -50.65% | 2.05% | 44.90% | -1.55% | Upgrade
|
| Free Cash Flow | - | 241.5 | 17.78 | 53.26 | 47.07 | Upgrade
|
| Free Cash Flow Per Share | - | 0.96 | 0.07 | 0.22 | 0.21 | Upgrade
|
| Dividend Per Share | - | 0.078 | 0.077 | 0.150 | 0.144 | Upgrade
|
| Dividend Growth | - | 0.91% | -48.64% | 4.66% | - | Upgrade
|
| Gross Margin | 100.00% | 77.45% | 89.00% | 89.28% | 89.69% | Upgrade
|
| Operating Margin | 3.26% | 22.06% | 26.69% | 23.71% | 26.72% | Upgrade
|
| Profit Margin | 2.50% | 20.76% | 29.39% | 31.41% | 30.37% | Upgrade
|
| Free Cash Flow Margin | - | 52.45% | 2.74% | 8.98% | 12.06% | Upgrade
|
| EBITDA | 39.16 | 125.99 | 188.63 | 153.9 | 114.37 | Upgrade
|
| EBITDA Margin | 8.65% | 27.37% | 29.06% | 25.94% | 29.29% | Upgrade
|
| D&A For EBITDA | 24.41 | 24.41 | 15.35 | 13.19 | 10.04 | Upgrade
|
| EBIT | 14.75 | 101.58 | 173.28 | 140.71 | 104.33 | Upgrade
|
| EBIT Margin | 3.26% | 22.06% | 26.69% | 23.71% | 26.72% | Upgrade
|
| Effective Tax Rate | 47.83% | 15.74% | 15.02% | 10.21% | 13.43% | Upgrade
|
| Revenue as Reported | - | 460.39 | 649.15 | 593.36 | 390.43 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.